News

The Institute of Neurogenetics Welcomes Dr. Andona Milovanovic

We are extending a very warm welcome to Dr. Andona Milovanovic, a neurology resident from Belgrade, Serbia who just joined the Institute of Neurogenetics for a 5-month-long research visit.  Dr. Milovanovic works at the Neurology Clinic, University Clinical Center of Serbia in the field of neurodegenerative diseases with the team led by Prof. Dr. Vladimir […]

The Institute of Neurogenetics Welcomes Dr. Andona Milovanovic Read More »

Alexander Balck receives a grant from the Else Kröner-Fresenius Foundation to investigate epigenetic modifiers of Parkinson’s disease.

Alexander Balck from the Institute of Neurogenetics and Department of Neurology received >340.000€ from the Else Kröner-Fresenius Foundation (https://www.ekfs.de/) to conduct a longitudinal investigation of epigenetic Modifiers of Parkinson’s disease in the DeNoPa cohort (https://www.denopa.de/).

Alexander Balck receives a grant from the Else Kröner-Fresenius Foundation to investigate epigenetic modifiers of Parkinson’s disease. Read More »

Prof. Klein belongs to “Global Highly Cited Researchers 2022”

Each year, Clarivate™ recognizes the world’s most influential researchers ─ the chosen few who have been cited most often by their peers over the past decade. As of 2022, less than 7,000, or about 0.1% of the world’s researchers in 21 research areas and across multiple disciplines, have received this exclusive honor. Professor. Dr. Christine

Prof. Klein belongs to “Global Highly Cited Researchers 2022” Read More »

Jannik Prasuhn, MD, receives the “Parkinson Fellowship” scholarship of the Thiemann Foundation

Congratulations to Dr. med Jannik Prasuhn, who received the Thiemann Foundation fellowship, the so-called “Parkinson Fellowship” aims in this respect to fill a gap in the research of neurodegenerative diseases and has been awarded annually since 2015. The foundation has already supported several highly qualified award recipients, fascinating research endeavors, and educational publications, and it

Jannik Prasuhn, MD, receives the “Parkinson Fellowship” scholarship of the Thiemann Foundation Read More »

Photo of Leonie Blöbaum

The Institute of Neurogenetics is happy to welcome Leonie Blöbaum

Leonie Blöbaum is a Master’s student of Molecular Life Science at the University of Lübeck. She obtained her BSc degree from the University of Lübeck, where she investigated the localization of circadian transcription factors during nuclear export inhibition. During previous internships, she gathered practical training in the Quality Systems and Compliance department at GSK Vaccines,

The Institute of Neurogenetics is happy to welcome Leonie Blöbaum Read More »

The Institute of Neurogenetics is happy to welcome Tuğçe Gül from Koç University

Tuğçe Gül, a Suna Kıraç Scholar, is a visiting PhD student that has graduated from Yıldız Technical University, Molecular Biology and Genetics Department. Her undergraduate thesis investigated SOD1 mutations in Turkish ALS patients. She obtained her MSc degree from Yeditepe University, Molecular Medicine Department during which she investigated the effect of miRNA-148a expression on LDL

The Institute of Neurogenetics is happy to welcome Tuğçe Gül from Koç University Read More »

The Integrative Omics team has received >$400,000 USD from the Michael J. Fox Foundation for gene-environment onset modifiers in Parkinson’s Disease

The initial study “Investigation of environmental factors in idiopathic and LRRK2-related Parkinson’s disease” was funded by the Michael J. Fox Foundation in 2021 and they are pleased to announce yet another successful grant for the project “Interaction of mitochondrial genes and lifestyle factors on age at onset in idiopathic and LRRK2 Parkinson’s disease”. Carolin and Joanne have recently

The Integrative Omics team has received >$400,000 USD from the Michael J. Fox Foundation for gene-environment onset modifiers in Parkinson’s Disease Read More »

PD Dr. Joanne Trinh, Prof. Christine Klein, and Prof. Markus Glatzel have received >€300,000 from the DFG to study the impact of Covid on Parkinson’s disease

The influence of COVID-19 on PD is largely unknown and elucidating the impact of SARS-CoV-2 on PD has a large potential for understanding the risk SARS-CoV-2 infection poses with respect to acceleration of subclinical PD and to understand prognosis of PD. In this project, the team will map relevant inflammatory biological pathways relevant to PD

PD Dr. Joanne Trinh, Prof. Christine Klein, and Prof. Markus Glatzel have received >€300,000 from the DFG to study the impact of Covid on Parkinson’s disease Read More »